Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707652 · ClinicalTrials.gov registry record · NA
Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03707652: Completed NA study, sponsored by Supplement Formulators.
NCT03707652 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03707652, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.
Primary Outcome
Mean change in NAD+ levels
Interventions
- DIETARY_SUPPLEMENT Oral supplement A
- DIETARY_SUPPLEMENT Oral supplement B
- DIETARY_SUPPLEMENT Oral supplement C
- DIETARY_SUPPLEMENT Oral supplement D
- DIETARY_SUPPLEMENT Oral Supplement D in combination with oral supplement C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2018-05-24 |
| Phase | NA |
What the finished NCT03707652 record still lists
NCT03707652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Oral supplement A is the first listed.
NCT03707652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03707652 about?
NCT03707652 is a clinical study titled "Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)". The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.
What is the current status of trial NCT03707652?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-03-12. Estimated completion is 2018-05-24.
What interventions are being tested in trial NCT03707652?
The interventions under investigation include: Oral supplement A (DIETARY_SUPPLEMENT), Oral supplement B (DIETARY_SUPPLEMENT), Oral supplement C (DIETARY_SUPPLEMENT), Oral supplement D (DIETARY_SUPPLEMENT), Oral Supplement D in combination with oral supplement C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03707652?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03707652's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI